Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Sale |
2024-12-17 6:06 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
577 | $0.35871 | $207 | 28,602 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-03 9:54 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
7,175 | $0.55 | $3,946 | 20,279 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:21 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
356 | $0.6899 | $246 | 14,956 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:26 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
372 | $1.2622 | $470 | 15,312 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:32 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,069 | $2.635 | $2,817 | 15,684 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-16 8:32 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
5,000 | $27.17 | $135,864 | 1,500 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-16 6:02 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
2,084 | $19.5 | $40,638 | 48,753 (Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $48.15 | $180,563 | 81,648 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-22 Option Award |
2025-04-01 6:07 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
2,500 | $0 | 2,500 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
65 | $0 | 1,989 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 8:00 pm |
N/A 2035-01-07 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:06 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,083 | $0 | 28,602 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:54 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
21,250 | $0 | 20,279 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:21 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,084 | $0 | 14,956 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,083 | $0 | 15,312 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:32 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
2,771 | $0 | 15,684 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:23 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
70,311 | $0 | 70,311 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:52 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
521 | $0 | 7,753 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:49 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
521 | $0 | 7,753 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:42 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
521 | $0 | 7,753 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:32 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
5,000 | $0 | 1,500 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:35 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-03-14 Exercise |
2023-03-16 6:02 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
2,084 | $0 | 48,753 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-16 6:02 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
41,000 | $0 | 48,753 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:16 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
72,156 | $0 | 72,156 (Direct) |
View |
| 2022-05-14 Option Award |
2022-05-17 3:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Senior VP and CFO |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:20 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
50,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 4:16 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
41,687 | $0 | 41,687 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:02 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
18,351 | $0 | 18,351 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:16 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 8:45 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:15 pm |
N/A 2027-10-02 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $0 | 81,648 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $5.55 | 81,648 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:03 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2020-05-26 Option Award |
2020-05-28 4:16 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-19 2:06 pm |
N/A 2030-05-15 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
45,000 | $0 | 45,000 (Direct) |
View |